Section Arrow
WGS.NASDAQ
- GeneDx Holdings Corp
Quotes are at least 15-min delayed:2025/09/17 15:12 EDT
Regular Hours
Last
 127.815
+6.445 (+5.31%)
Day High 
129.47 
Prev. Close
121.37 
1-M High
136 
Volume 
343.78K 
Bid
127.19
Ask
128.44
Day Low
121.53 
Open
121.7 
1-M Low
114.2501 
Market Cap 
3.49B 
Currency USD 
P/E 1,517.13 
%Yield -- 
10-SMA 126.18 
20-SMA 125.8 
50-SMA 108.2 
52-W High 136 
52-W Low 35.88 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.08/-0.05
Enterprise Value
3.60B
Balance Sheet
Book Value Per Share
9.65
Cash Flow
Cash Flow Yield
0.00
Income Statement
Total Revenue
305.45M
Operating Revenue Per Share
7.19
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1828-0.0782-29.96%-- 
NEOGNeogen Corp5.485+0.215+4.08%879PE
NEONeoGenomics8.135+0.145+1.81%-- 
DHRDanaher Corp191.64+1.17+0.61%40.44PE
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
Quotes are at least 15-min delayed:2025/09/17 15:12 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.